Lupron and Zanaflex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lupron (leuprolide acetate) and Zanaflex (tizanidine hydrochloride). Common drug interactions include abdominal pain among females and full blood count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Lupron and Zanaflex. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Lupron?

Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.

What is Zanaflex?

Zanaflex has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 17,476 Zanaflex users. Check the latest studies of Zanaflex.



On Jul, 12, 2026

34 people who take Lupron and Zanaflex together, and have interactions are studied.

Lupron and Zanaflex drug interactions.

What are the common drug interactions of Lupron and Zanaflex, by gender? *:

female:

  1. Abdominal pain
  2. Vaginal haemorrhage (vaginal bleeding)
  3. Nausea (feeling of having an urge to vomit)
  4. Abortion spontaneous (naturally occurring miscarriage)
  5. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  6. Menstrual disorder (disease of menstrual cycle)
  7. Polycystic ovaries (cysts in the ovaries that occurs when the follicle stops developing)
  8. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
  9. Abdominal pain lower
  10. Depression

male:

  1. Full blood count decreased
  2. Ulcer haemorrhage (bleeding ulcer)
  3. Blood iron decreased
  4. Prostatic specific antigen increased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Pneumonia
  7. Blood creatinine increased
  8. Pain in extremity
  9. Weight decreased

What are the common drug interactions of Lupron and Zanaflex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain lower
  2. Headache (pain in head)
  3. Hospitalisation
  4. Increased appetite
  5. Kidney infection
  6. Maternal exposure before pregnancy (use of substance before pregnancy)
  7. Nausea (feeling of having an urge to vomit)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Pregnancy
  10. Sleep disorder

30-39:

  1. Throat tightness
  2. Drug hypersensitivity
  3. Mass
  4. Arthralgia (joint pain)
  5. Back pain
  6. Headache (pain in head)
  7. Influenza
  8. Local swelling (swelling at the site of some application of substance or injury)
  9. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  10. Migraine (headache)

40-49:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Anal haemorrhage
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Chest pain
  6. Depression
  7. Diarrhoea
  8. Dizziness
  9. Headache (pain in head)
  10. Hepatic steatosis (fatty liver disease)

50-59:

  1. Influenza like illness
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Headache (pain in head)

60+:

  1. Full blood count decreased
  2. Ulcer haemorrhage (bleeding ulcer)
  3. Blood iron decreased
  4. Prostatic specific antigen increased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Pneumonia
  7. Blood creatinine increased
  8. Pain in extremity
  9. Weight decreased

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 17.65%
  2. Pain: 6 people, 17.65%
  3. Stress And Anxiety: 6 people, 17.65%
  4. Depression: 5 people, 14.71%
  5. Prostate Cancer Metastatic: 5 people, 14.71%
  6. Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 3 people, 8.82%
  7. Nausea (feeling of having an urge to vomit): 3 people, 8.82%
  8. Back Pain: 3 people, 8.82%
  9. Metastases To Bone (cancer spreads to bone): 3 people, 8.82%
  10. Neuralgia (pain in one or more nerves): 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Lupron and Zanaflex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lupron and Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lupron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lupron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zanaflex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate and tizanidine hydrochloride (the active ingredients of Lupron and Zanaflex, respectively), and Lupron and Zanaflex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: